News Search Results
Oct 21, 2025, 05:00 ET Corra Group Advances Background Screening with AI to Improve Accuracy, Build Trust, and Elevate the Customer Experience
Futurist Amy Webb also describes the moment we're in as a "technology supercycle," where AI, biotechnology, and connected devices are reshaping how society and business operate. For
More news about: Corra Group
Oct 20, 2025, 19:39 ET BIOVAXYS ANNOUNCES CONVERSION OF DEBENTURES AND GRANT OF STOCK OPTIONS
receive the required regulatory approvals. With regards to BioVaxys' business, there are a number of risks that could affect the development of its biotechnology products, including, without limitation, the need for additional capital to fund clinical trials, its lack of operating history, uncertainty about
More news about: BioVaxys Technology Corp.
Oct 20, 2025, 16:28 ET CaseBioscience® Launches CaseBio™ Culture and CaseBio™ Handling Media at ASRM 2025 After FDA 510(k) Clearance and Clinical Evaluation
PETERSBURG, Fla., Oct. 20, 2025 /PRNewswire/ -- CaseBioscience® is driving a new era of innovation in biotechnology by uniting Assisted Reproductive Technology (ART) with breakthroughs in stem cell science. Over the past three years, the company's research and
More news about: CaseBioscience Inc.
Oct 20, 2025, 14:31 ET Sōlaria Biō Announces New Bone Health Breakthrough with Bondia™
Sōlaria Biō, a biotechnology company pioneering natural solutions for healthy aging, today launched
More news about: Sōlaria Biō
Oct 20, 2025, 13:08 ET LabConnect Featured in Season Finale of Emmy-Nominated Series Tomorrow's World Today
About LabConnect LabConnect is redefining central laboratory services as a technology-driven partner for pharmaceutical and biotechnology companies. Our decentralized network model provides sponsors with access to the industry's most comprehensive global testing menu, supported by
More news about: LabConnect
Oct 20, 2025, 13:00 ET LabConnect Featured in Season Finale of Emmy-Nominated Series Tomorrow's World Today
About LabConnect LabConnect is redefining central laboratory services as a technology-driven partner for pharmaceutical and biotechnology companies. Our decentralized network model provides sponsors with access to the industry's most comprehensive global testing menu,
More news about: LabConnect
Oct 20, 2025, 12:00 ET Benchling Partners with Anthropic to Build a Bridge Between Science and AI
and more information. About BenchlingBenchling's mission is to unlock the power of biotechnology. Founded in 2012, Benchling provides a unified, cloud-based platform trusted by more than 1,300 biotech companies worldwide, from pioneering startups
More news about: Benchling
Oct 20, 2025, 12:00 ET Benchling Partners with Anthropic to Build a Bridge Between Science and AI
and more information. About BenchlingBenchling's mission is to unlock the power of biotechnology. Founded in 2012, Benchling provides a unified, cloud-based platform trusted by more than 1,300 biotech companies worldwide, from pioneering startups
More news about: Benchling
Oct 20, 2025, 11:00 ET Plug and Play Lifetech Announces Inaugural Batch of 12 Innovative Startups in Indianapolis
a leader in life sciences innovation. The program supports startups developing breakthroughs in therapeutics, diagnostics, medical devices, and biotechnology through mentorship, investor access, and corporate collaboration. To learn more about Plug and Play Lifetech, visit:
More news about: Plug and Play
Oct 20, 2025, 10:34 ET MetaVia Announces Poster Presentations on DA-1726 at ObesityWeek® 2025
CAMBRIDGE, Mass., Oct. 20, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that two abstracts highlighting data on DA-1726, a novel, dual oxyntomodulin
More news about: MetaVia Inc.
Oct 20, 2025, 10:01 ET Bone Regeneration Market to Reach $6.0 Billion by 2027 in the short term and $8.4 Billion by 2034 Globally, at 4.9% CAGR: Allied Market Research
differentiated technologies. In October 2024, Enovis announced its strategic partnership with Ossium Health, a clinical-stage biotechnology company, to distribute OssiGraft and OssiGraft Prime cryopreserved viable bone matrix (VBX) allografts through Enovis' extensive sales network.
More news about: Allied Market Research
Oct 20, 2025, 09:35 ET New NYC 'Liver ICU' Lab Transforming Liver Disease Treatments
NEW YORK, Oct. 20, 2025 /PRNewswire/ -- Ochre Bio, a biotechnology company developing RNA therapeutics for chronic liver disease, has opened a unique perfusion 'Liver ICU' lab in the Alexandria Centre for Life Sciences.
More news about: Ochre Bio
Oct 20, 2025, 09:28 ET MLTX INVESTOR DEADLINE: MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
later than December 15, 2025. CASE ALLEGATIONS: MoonLake is a clinical stage biotechnology company that focuses on developing therapies for inflammatory skin and joint diseases. According to the complaint, MoonLake's sole drug candidate
More news about: Robbins Geller Rudman & Dowd LLP
Oct 20, 2025, 09:00 ET Oncolytics Biotech® Files Circular/Prospectus for Special Meeting of Shareholders To Change Jurisdiction of Incorporation to Nevada
About Oncolytics Biotech Inc. Oncolytics is a clinical-stage biotechnology company developing pelareorep, an investigational intravenously delivered double-stranded RNA immunotherapeutic agent. Pelareorep has demonstrated
More news about: Oncolytics Biotech® Inc.
Oct 20, 2025, 08:33 ET GlycoNex Abstract on Glycan-Directed ADC GNX1021 Accepted for Presentation at AACR-NCI-EORTC 2025
GlycoNex, Inc. (4168, hereinafter referred to as GNX), a clinical stage biotechnology company focused on the development of glycan-directed cancer immunotherapies, today announced that an abstract describing preclinical research on
More news about: GlycoNex, Inc.
Oct 20, 2025, 08:33 ET Surf Bio to Present SnapShot™ Platform at PODD 2025, Showcasing Potential to Transform Subcutaneous Delivery of High-Dose Biologic Therapies
potential to redefine the accessibility, economics, and patient experience of biologic treatment. We look forward to connecting with pharmaceutical and biotechnology leaders at PODD 2025 to explore partnership opportunities that can leverage this platform." Surf Bio will be available throughout
More news about: Surf Bio, Inc.
Oct 20, 2025, 08:30 ET Driving Success in Therapeutics with Recombinant Antibody Production, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Oct 20, 2025, 08:30 ET From Signals to Strategy: The Next Chapter of Digital Biomarkers, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Oct 20, 2025, 08:25 ET Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the Chinese National Intellectual Property Administration (CNIPA)
More news about: Anixa Biosciences, Inc.
Oct 20, 2025, 07:00 ET HanchorBio Showcases Pipeline Momentum with HCB101 and HCB301 Data Across Five Major Oncology Meetings in Q4 2025
SAN FRANCISCO, Oct. 20, 2025 /PRNewswire/ -- HanchorBio Inc. (TPEx: 7827), a global clinical-stage biotechnology company developing next-generation immunotherapies, today announced that new clinical data from HCB101, its differentiated, engineered SIRPα-Fc
More news about: HanchorBio Inc.
Oct 20, 2025, 07:00 ET Leap Therapeutics Presents Final Data from DeFianCe Study at ESMO 2025
CAMBRIDGE, Mass., Oct. 20, 2025 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced final results from Part B of the DeFianCe study (
More news about: Leap Therapeutics, Inc.
Oct 20, 2025, 06:55 ET Protocatechuic Acid Market worth $24.0 million by 2030 - Exclusive Report by MarketsandMarkets™
skin-protective capabilities are increasingly utilized in the booming personal care and cosmetics sector. Moreover, technological advancements in biotechnology and green chemistry are enabling more sustainable and cost-effective production processes, thereby strengthening PCA's position as a vital ingredient
More news about: MarketsandMarkets
Oct 20, 2025, 06:13 ET Groundbreaking Study in the Journal of Clinical Investigation Advances Cell Therapy for Huntington's Disease Treatment
therapies against neurodegenerative disorders." [About Unixell Biotechnology] Shanghai Unixell Biotechnology, founded in 2021, focuses on developing cell therapies for neurological diseases such as Parkinson's disease
More news about: UniXell Biotechnology
Oct 20, 2025, 05:00 ET FDA Grants Orphan Drug Designation to Cellenkos' CK0803 Tregs for Treatment of Amyotrophic Lateral Sclerosis
HOUSTON, Oct. 20, 2025 /PRNewswire/ -- Cellenkos® Inc., a clinical-stage biotechnology company focused on developing allogeneic, off-the-shelf, T regulatory (Treg) cell therapies for autoimmune diseases and inflammatory disorders especially
More news about: Cellenkos, Inc.
Oct 20, 2025, 03:41 ET AgiBot Shines at GITEX GLOBAL 2025, Developing Comprehensive Humanoid Solutions and Connecting Intelligent Future
edition, GITEX GLOBAL stands as the world's most established and iconic large-scale tech exhibition exploring breakthroughs in AI, quantum computing, biotechnology and sustainable technology that are transforming global infrastructure and growth. Built on the foundation of robot ontology
More news about: AgiBot Innovation (Shanghai) Technology Co.,Ltd.